Norge - norska - Statens legemiddelverk

exeltis healthcare s.l. (1) - drospirenon - tablett, filmdrasjert - 4 mg

Europeiska unionen - norska - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Europeiska unionen - norska - EMA (European Medicines Agency)

extrovis eu ltd. - lakosamid - epilepsi - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Europeiska unionen - norska - EMA (European Medicines Agency)

bial - portela ca, s.a. - eslikarbazepinacetat - epilepsi - antiepileptics, - exalief er angitt som tilleggsbehandling behandling hos voksne med delvis-utbruddet anfall med eller uten sekundær generalisering.

Europeiska unionen - norska - EMA (European Medicines Agency)

bial - portela & ca, s.a. - eslikarbazepinacetat - epilepsi - antiepileptics, - zebinix er indisert som tilleggsbehandling hos voksne, ungdommer og barn i alderen over 6 år, med partielle anfall med eller uten sekundær generalisering.

Norge - norska - Statens legemiddelverk

orifarm as - topiramat - tablett, filmdrasjert - 200 mg

Norge - norska - Statens legemiddelverk

janssen-cilag as - topiramat - kapsel, hard - 15 mg

Norge - norska - Statens legemiddelverk

janssen-cilag as - topiramat - kapsel, hard - 25 mg

Norge - norska - Statens legemiddelverk

janssen-cilag as - topiramat - tablett, filmdrasjert - 25 mg

Norge - norska - Statens legemiddelverk

janssen-cilag as - topiramat - tablett, filmdrasjert - 50 mg